Abstract

ENWEndNote BIBJabRef, Mendeley RISPapers, Reference Manager, RefWorks, Zotero AMA Gut P, Fischbach J, Baszko-Błaszyk D, Fichna M, Gryczyńska M, Ruchała M. Lanreotide therapy in a case of thymic neuroendocrine carcinoma associated with syndrome of inappropriate antidiuretic hormone secretion. Contemporary Oncology/Współczesna Onkologia. 2011;15(6):407-410. doi:10.5114/wo.2011.26447. APA Gut, P., Fischbach, J., Baszko-Błaszyk, D., Fichna, M., Gryczyńska, M., & Ruchała, M. (2011). Lanreotide therapy in a case of thymic neuroendocrine carcinoma associated with syndrome of inappropriate antidiuretic hormone secretion. Contemporary Oncology/Współczesna Onkologia, 15(6), 407-410. https://doi.org/10.5114/wo.2011.26447 Chicago Gut, Paweł, Jakub Fischbach, Daria Baszko-Błaszyk, Marta Fichna, Maria Gryczyńska, and Marek Ruchała. 2011. "Lanreotide therapy in a case of thymic neuroendocrine carcinoma associated with syndrome of inappropriate antidiuretic hormone secretion". Contemporary Oncology/Współczesna Onkologia 15 (6): 407-410. doi:10.5114/wo.2011.26447. Harvard Gut, P., Fischbach, J., Baszko-Błaszyk, D., Fichna, M., Gryczyńska, M., and Ruchała, M. (2011). Lanreotide therapy in a case of thymic neuroendocrine carcinoma associated with syndrome of inappropriate antidiuretic hormone secretion. Contemporary Oncology/Współczesna Onkologia, 15(6), pp.407-410. https://doi.org/10.5114/wo.2011.26447 MLA Gut, Paweł et al. "Lanreotide therapy in a case of thymic neuroendocrine carcinoma associated with syndrome of inappropriate antidiuretic hormone secretion." Contemporary Oncology/Współczesna Onkologia, vol. 15, no. 6, 2011, pp. 407-410. doi:10.5114/wo.2011.26447. Vancouver Gut P, Fischbach J, Baszko-Błaszyk D, Fichna M, Gryczyńska M, Ruchała M. Lanreotide therapy in a case of thymic neuroendocrine carcinoma associated with syndrome of inappropriate antidiuretic hormone secretion. Contemporary Oncology/Współczesna Onkologia. 2011;15(6):407-410. doi:10.5114/wo.2011.26447.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call